Status:
COMPLETED
Safer Use of Antipsychotics in Youth
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
Nationwide Children's Hospital
Seattle Children's Hospital
Conditions:
Child Behavior Disorders
Eligibility:
All Genders
3-17 years
Phase:
NA
Brief Summary
This study tests the effectiveness of an intervention treatment algorithm vs. usual care control in a practical clinical trial. Control arm providers will receive a standard medication alert in the el...
Detailed Description
SUAY is a practical clinical trial designed to test the effectiveness of an intervention aiming to improve the targeted and safer use of antipsychotic medications by guiding clinician-prescribing beha...
Eligibility Criteria
Inclusion
- Patient is ≥ 3 and \< 18 years of age at the time of the encounter at which the study alert fired (index date);
- Patient is initiating a new episode of outpatient treatment with an antipsychotic medication. (New episodes are defined by no record of an antipsychotic medication being ordered within the health system as part of an outpatient care plan in the prior 180 days);
- Study service (BH navigation, bridging therapy, CAP consult) ordered in Epic for the patient; (e.g., provider removed antipsychotic order and still ordered study services);
Exclusion
- Patient has a diagnosed psychotic disorder, mania, autism spectrum disorder, or intellectual disability;
- Patient was enrolled in the SUAY pilot study;
- The antipsychotic entered is prochlorperazine (Comazol®);
- An outpatient antipsychotic order is entered by a temporary provider in the health system (e.g., "doc of the day"). Orders placed by temporary providers do not count towards the 180 day medication free period for defining a new episode of care.
- The antipsychotic order was placed within an urgent care, emergency department, or inpatient setting (to avoid intervening during a crisis). Orders placed in these settings do not count towards the 180 day medication free period for defining a new episode of care.
- Primary language is not English
Key Trial Info
Start Date :
March 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 24 2021
Estimated Enrollment :
733 Patients enrolled
Trial Details
Trial ID
NCT03448575
Start Date
March 29 2018
End Date
December 24 2021
Last Update
October 31 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Colorado Institute for Health Research
Aurora, Colorado, United States, 80014
2
Nationwide Children's Hospital / Partners for Kids
Columbus, Ohio, United States, 43205
3
Kaiser Permanente Center for Health Research - Northwest
Portland, Oregon, United States, 97227
4
Kaiser Permanente Washington Health Research Institute
Seattle, Washington, United States, 98115